Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1358820 (Botox) for Urinary Incontinence in NDO
NCT02849418Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in neurogenic detrusor overactivity (NDO), urinary incontinence (UI), sponsored by GSK. Started Oct 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
neurogenic detrusor overactivity (NDO)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT02849418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849418.